Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Conjunctivitis, Allergic | 55 | 2017 | 124 | 8.440 |
Why?
|
Anti-Allergic Agents | 25 | 2017 | 157 | 3.820 |
Why?
|
Dibenzoxepins | 20 | 2008 | 28 | 3.610 |
Why?
|
Ophthalmic Solutions | 55 | 2011 | 312 | 3.530 |
Why?
|
Dry Eye Syndromes | 17 | 2017 | 384 | 3.510 |
Why?
|
Histamine H1 Antagonists | 22 | 2005 | 101 | 3.170 |
Why?
|
Tears | 20 | 2017 | 253 | 1.570 |
Why?
|
Allergens | 27 | 2017 | 1444 | 1.520 |
Why?
|
Blinking | 4 | 2017 | 135 | 1.470 |
Why?
|
Rhinitis, Allergic, Seasonal | 7 | 2017 | 104 | 1.390 |
Why?
|
Cornea | 16 | 2017 | 1315 | 1.160 |
Why?
|
Vision Tests | 2 | 2020 | 160 | 1.160 |
Why?
|
Conjunctiva | 29 | 2011 | 475 | 1.100 |
Why?
|
Atrial Appendage | 3 | 2024 | 285 | 1.040 |
Why?
|
Ketotifen | 5 | 2008 | 24 | 0.970 |
Why?
|
Piperidines | 12 | 2011 | 1669 | 0.900 |
Why?
|
Loratadine | 5 | 2004 | 14 | 0.830 |
Why?
|
Histamine Antagonists | 4 | 2015 | 94 | 0.760 |
Why?
|
Septal Occluder Device | 2 | 2024 | 126 | 0.720 |
Why?
|
Double-Blind Method | 46 | 2017 | 12469 | 0.710 |
Why?
|
Histamine H1 Antagonists, Non-Sedating | 4 | 2008 | 17 | 0.670 |
Why?
|
Conjunctivitis | 12 | 2003 | 153 | 0.630 |
Why?
|
Vision Disorders | 3 | 2020 | 1093 | 0.610 |
Why?
|
Antipruritics | 1 | 2017 | 31 | 0.590 |
Why?
|
Menthol | 1 | 2017 | 26 | 0.590 |
Why?
|
Rhinitis, Allergic, Perennial | 4 | 2005 | 60 | 0.570 |
Why?
|
Phleum | 1 | 2017 | 5 | 0.570 |
Why?
|
Atmosphere Exposure Chambers | 1 | 2017 | 51 | 0.560 |
Why?
|
Pruritus | 8 | 2011 | 379 | 0.540 |
Why?
|
TRPM Cation Channels | 1 | 2017 | 141 | 0.540 |
Why?
|
Keratoconjunctivitis Sicca | 2 | 2015 | 26 | 0.530 |
Why?
|
Benzimidazoles | 4 | 2002 | 864 | 0.470 |
Why?
|
Fluorescein | 1 | 2015 | 175 | 0.470 |
Why?
|
Administration, Topical | 15 | 2011 | 704 | 0.470 |
Why?
|
Eye Diseases | 12 | 2003 | 658 | 0.460 |
Why?
|
Circadian Rhythm | 5 | 2016 | 2593 | 0.460 |
Why?
|
Dibenzazepines | 2 | 2004 | 26 | 0.460 |
Why?
|
Imidazoles | 6 | 2004 | 1169 | 0.420 |
Why?
|
Macular Degeneration | 1 | 2020 | 1016 | 0.420 |
Why?
|
Reading | 1 | 2015 | 543 | 0.380 |
Why?
|
Visual Acuity | 8 | 2020 | 2714 | 0.380 |
Why?
|
Conjunctivitis, Bacterial | 2 | 2008 | 22 | 0.370 |
Why?
|
Staining and Labeling | 3 | 2015 | 1081 | 0.370 |
Why?
|
Hyperemia | 7 | 2011 | 224 | 0.360 |
Why?
|
Quinoxalines | 2 | 2003 | 297 | 0.360 |
Why?
|
Pyridines | 5 | 2011 | 2896 | 0.350 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 7 | 2015 | 2277 | 0.340 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2015 | 709 | 0.340 |
Why?
|
Keratoconjunctivitis | 4 | 2006 | 41 | 0.340 |
Why?
|
Azithromycin | 2 | 2008 | 201 | 0.340 |
Why?
|
Mast Cells | 7 | 2015 | 1406 | 0.330 |
Why?
|
Embolectomy | 1 | 2010 | 130 | 0.330 |
Why?
|
Stroke | 3 | 2020 | 9756 | 0.320 |
Why?
|
Ocular Hypertension | 4 | 2003 | 211 | 0.310 |
Why?
|
Eyelids | 5 | 2009 | 279 | 0.310 |
Why?
|
Ketorolac | 2 | 1999 | 95 | 0.300 |
Why?
|
Eye | 7 | 2002 | 712 | 0.300 |
Why?
|
Histamine | 10 | 2003 | 496 | 0.290 |
Why?
|
Hypersensitivity | 8 | 2006 | 1173 | 0.290 |
Why?
|
Contact Lenses | 5 | 2004 | 137 | 0.270 |
Why?
|
p-Methoxy-N-methylphenethylamine | 5 | 1990 | 41 | 0.270 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2008 | 238 | 0.260 |
Why?
|
Androstadienes | 3 | 2008 | 348 | 0.250 |
Why?
|
Middle Aged | 60 | 2024 | 223740 | 0.250 |
Why?
|
Hydroxycorticosteroids | 1 | 2005 | 3 | 0.250 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2008 | 342 | 0.250 |
Why?
|
Cetirizine | 1 | 2004 | 7 | 0.240 |
Why?
|
Humans | 133 | 2024 | 768887 | 0.240 |
Why?
|
Warfarin | 1 | 2013 | 1493 | 0.230 |
Why?
|
Skin Tests | 4 | 2017 | 639 | 0.230 |
Why?
|
Atrial Fibrillation | 3 | 2024 | 5176 | 0.220 |
Why?
|
Adult | 62 | 2017 | 223818 | 0.220 |
Why?
|
Safety | 7 | 2003 | 1159 | 0.220 |
Why?
|
Ocular Physiological Phenomena | 2 | 2016 | 67 | 0.220 |
Why?
|
Treatment Outcome | 25 | 2024 | 65485 | 0.220 |
Why?
|
Male | 73 | 2024 | 365249 | 0.210 |
Why?
|
Contrast Sensitivity | 2 | 2015 | 253 | 0.210 |
Why?
|
Aged | 40 | 2024 | 171790 | 0.210 |
Why?
|
Disposable Equipment | 2 | 1993 | 46 | 0.210 |
Why?
|
Contact Lenses, Hydrophilic | 2 | 1993 | 53 | 0.210 |
Why?
|
Naphazoline | 4 | 1990 | 7 | 0.210 |
Why?
|
Glaucoma | 2 | 2003 | 1194 | 0.210 |
Why?
|
Seasons | 10 | 2005 | 1523 | 0.200 |
Why?
|
Cross-Over Studies | 6 | 2017 | 2108 | 0.200 |
Why?
|
Female | 68 | 2024 | 397464 | 0.200 |
Why?
|
Eyelid Diseases | 3 | 2000 | 157 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 13 | 2011 | 10778 | 0.190 |
Why?
|
Models, Biological | 10 | 2008 | 9499 | 0.180 |
Why?
|
Pollen | 2 | 2016 | 80 | 0.180 |
Why?
|
Cataract Extraction | 4 | 1995 | 465 | 0.180 |
Why?
|
Edema | 2 | 2005 | 766 | 0.170 |
Why?
|
Pyrimidinones | 1 | 2002 | 386 | 0.170 |
Why?
|
Intraocular Pressure | 5 | 2003 | 1304 | 0.170 |
Why?
|
Antazoline | 4 | 1990 | 6 | 0.160 |
Why?
|
Device Removal | 1 | 2024 | 643 | 0.160 |
Why?
|
Adolescent | 27 | 2017 | 89247 | 0.160 |
Why?
|
Time Factors | 19 | 2024 | 40266 | 0.150 |
Why?
|
Quality of Life | 3 | 2017 | 13510 | 0.150 |
Why?
|
Prospective Studies | 14 | 2020 | 54950 | 0.150 |
Why?
|
Thermoreceptors | 1 | 2017 | 27 | 0.150 |
Why?
|
Macular Edema | 2 | 1995 | 387 | 0.150 |
Why?
|
Cardiac Surgical Procedures | 1 | 2013 | 3683 | 0.140 |
Why?
|
Anticoagulants | 1 | 2013 | 4850 | 0.140 |
Why?
|
Brain Ischemia | 1 | 2010 | 3008 | 0.140 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2017 | 144 | 0.140 |
Why?
|
Poaceae | 1 | 2016 | 25 | 0.140 |
Why?
|
Cromolyn Sodium | 2 | 1995 | 78 | 0.140 |
Why?
|
Corneal Diseases | 5 | 1994 | 535 | 0.130 |
Why?
|
Immunologic Techniques | 1 | 2016 | 213 | 0.130 |
Why?
|
Aged, 80 and over | 12 | 2024 | 59738 | 0.130 |
Why?
|
South Africa | 2 | 2013 | 1872 | 0.130 |
Why?
|
Amine Oxidase (Copper-Containing) | 1 | 1995 | 41 | 0.130 |
Why?
|
Glaucoma, Open-Angle | 1 | 2003 | 742 | 0.130 |
Why?
|
Hypersensitivity, Immediate | 2 | 2003 | 349 | 0.130 |
Why?
|
Immunoglobulin E | 2 | 2017 | 1506 | 0.130 |
Why?
|
Flurbiprofen | 1 | 1995 | 21 | 0.120 |
Why?
|
Anti-Bacterial Agents | 4 | 2008 | 7472 | 0.120 |
Why?
|
Eosinophils | 6 | 1989 | 953 | 0.120 |
Why?
|
Child | 22 | 2011 | 80969 | 0.120 |
Why?
|
Biomedical Research | 1 | 2010 | 3463 | 0.120 |
Why?
|
Hyaluronoglucosaminidase | 2 | 1998 | 138 | 0.120 |
Why?
|
Drug Administration Schedule | 6 | 2009 | 4862 | 0.120 |
Why?
|
Indomethacin | 1 | 1995 | 323 | 0.110 |
Why?
|
Endophthalmitis | 2 | 1994 | 262 | 0.110 |
Why?
|
Intelligence Tests | 1 | 2015 | 505 | 0.110 |
Why?
|
Probability | 4 | 2003 | 2483 | 0.110 |
Why?
|
Blepharitis | 3 | 2004 | 35 | 0.110 |
Why?
|
Terfenadine | 2 | 2003 | 16 | 0.110 |
Why?
|
Contact Lenses, Extended-Wear | 1 | 1993 | 12 | 0.110 |
Why?
|
Acute Disease | 6 | 2008 | 7245 | 0.110 |
Why?
|
Nose | 1 | 2017 | 523 | 0.110 |
Why?
|
Reference Values | 5 | 2003 | 4941 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2001 | 2026 | 0.100 |
Why?
|
Lipids | 1 | 2003 | 3345 | 0.100 |
Why?
|
Vision, Ocular | 1 | 1995 | 458 | 0.090 |
Why?
|
Keratitis | 5 | 2002 | 241 | 0.090 |
Why?
|
Clinical Trials as Topic | 5 | 2008 | 8055 | 0.090 |
Why?
|
Immunomodulation | 1 | 2015 | 549 | 0.090 |
Why?
|
Electromyography | 1 | 2016 | 1402 | 0.090 |
Why?
|
Severity of Illness Index | 6 | 2009 | 15955 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 3 | 2002 | 1813 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2020 | 20244 | 0.090 |
Why?
|
Drug Evaluation | 3 | 2000 | 642 | 0.090 |
Why?
|
Keratitis, Dendritic | 3 | 1978 | 18 | 0.080 |
Why?
|
Burns, Chemical | 4 | 1992 | 123 | 0.080 |
Why?
|
Piroxicam | 1 | 1989 | 18 | 0.080 |
Why?
|
Dexamethasone | 1 | 2017 | 1965 | 0.080 |
Why?
|
Epilepsy, Complex Partial | 1 | 2009 | 59 | 0.080 |
Why?
|
Vasoconstrictor Agents | 2 | 1984 | 657 | 0.080 |
Why?
|
Models, Immunological | 2 | 2003 | 518 | 0.080 |
Why?
|
Vigabatrin | 1 | 2009 | 88 | 0.080 |
Why?
|
Pharmaceutical Vehicles | 1 | 2008 | 56 | 0.080 |
Why?
|
Vasodilation | 3 | 1981 | 967 | 0.080 |
Why?
|
Anterior Eye Segment | 1 | 2009 | 144 | 0.080 |
Why?
|
Leukotriene B4 | 1 | 1989 | 281 | 0.070 |
Why?
|
Registries | 1 | 2024 | 8384 | 0.070 |
Why?
|
Immunologic Tests | 2 | 2003 | 104 | 0.070 |
Why?
|
Verapamil | 1 | 1988 | 242 | 0.070 |
Why?
|
Tobramycin | 1 | 2007 | 65 | 0.070 |
Why?
|
Delayed-Action Preparations | 1 | 2011 | 969 | 0.070 |
Why?
|
Statistics, Nonparametric | 2 | 2003 | 2862 | 0.070 |
Why?
|
Gram-Positive Bacteria | 1 | 2008 | 178 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 1933 | 0.070 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2004 | 361 | 0.070 |
Why?
|
Arachidonic Acids | 1 | 1987 | 296 | 0.070 |
Why?
|
Gram-Negative Bacteria | 1 | 2008 | 274 | 0.070 |
Why?
|
Eye Burns | 3 | 1992 | 64 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2015 | 1893 | 0.060 |
Why?
|
Administration, Oral | 5 | 2003 | 4042 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39394 | 0.060 |
Why?
|
Eye Movements | 1 | 1989 | 514 | 0.060 |
Why?
|
Environment | 2 | 2002 | 1125 | 0.060 |
Why?
|
Young Adult | 6 | 2017 | 60110 | 0.060 |
Why?
|
Rabbits | 12 | 1998 | 4774 | 0.060 |
Why?
|
Spasms, Infantile | 1 | 2009 | 301 | 0.060 |
Why?
|
Drug Therapy, Combination | 4 | 2002 | 6320 | 0.060 |
Why?
|
Cerebral Angiography | 1 | 2010 | 1272 | 0.060 |
Why?
|
Alkalies | 4 | 1992 | 45 | 0.060 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 811 | 0.060 |
Why?
|
Hypergammaglobulinemia | 1 | 1984 | 71 | 0.060 |
Why?
|
Child, Preschool | 10 | 2008 | 42684 | 0.060 |
Why?
|
Photophobia | 1 | 2005 | 77 | 0.060 |
Why?
|
Pregnadienediols | 1 | 2003 | 9 | 0.060 |
Why?
|
Environmental Exposure | 1 | 1999 | 4538 | 0.050 |
Why?
|
Lenses, Intraocular | 3 | 1995 | 141 | 0.050 |
Why?
|
Medical Records | 1 | 1989 | 1411 | 0.050 |
Why?
|
Tablets | 2 | 2003 | 149 | 0.050 |
Why?
|
Administration, Intranasal | 4 | 2008 | 485 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2005 | 309 | 0.050 |
Why?
|
Cloprostenol | 1 | 2003 | 21 | 0.050 |
Why?
|
Eye Color | 1 | 2002 | 35 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3529 | 0.050 |
Why?
|
Ribonucleases | 1 | 1983 | 266 | 0.050 |
Why?
|
Lactones | 1 | 2004 | 316 | 0.050 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2004 | 232 | 0.050 |
Why?
|
Physical Examination | 1 | 1988 | 1262 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1987 | 1339 | 0.050 |
Why?
|
Receptors, Histamine H2 | 1 | 1981 | 18 | 0.050 |
Why?
|
Microbial Sensitivity Tests | 1 | 2008 | 1963 | 0.050 |
Why?
|
Receptors, Histamine | 1 | 1981 | 23 | 0.050 |
Why?
|
Injections | 2 | 1998 | 841 | 0.050 |
Why?
|
Histamine Release | 1 | 1981 | 134 | 0.050 |
Why?
|
Leukocyte Count | 4 | 1989 | 1609 | 0.050 |
Why?
|
Software | 1 | 2015 | 4480 | 0.050 |
Why?
|
Rose Bengal | 3 | 1998 | 115 | 0.040 |
Why?
|
Placebos | 1 | 2005 | 1668 | 0.040 |
Why?
|
Embolism | 1 | 2024 | 401 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2003 | 1629 | 0.040 |
Why?
|
Drug Tolerance | 3 | 1994 | 366 | 0.040 |
Why?
|
Suspensions | 1 | 2000 | 68 | 0.040 |
Why?
|
Amides | 1 | 2003 | 452 | 0.040 |
Why?
|
Rosacea | 1 | 1980 | 60 | 0.040 |
Why?
|
Algorithms | 2 | 2016 | 14199 | 0.040 |
Why?
|
Cognition | 2 | 2015 | 7080 | 0.040 |
Why?
|
United States Food and Drug Administration | 2 | 2002 | 1672 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2003 | 1133 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2015 | 22294 | 0.040 |
Why?
|
Corneal Transplantation | 2 | 1980 | 315 | 0.040 |
Why?
|
Lasers | 1 | 2003 | 952 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2009 | 1924 | 0.040 |
Why?
|
Risk Factors | 3 | 2024 | 74971 | 0.040 |
Why?
|
Keratoconus | 1 | 1980 | 112 | 0.040 |
Why?
|
Chondroitin | 1 | 1998 | 64 | 0.040 |
Why?
|
Tolmetin | 1 | 1998 | 24 | 0.040 |
Why?
|
Eye Proteins | 1 | 1981 | 628 | 0.040 |
Why?
|
Adaptation, Physiological | 2 | 2002 | 1315 | 0.040 |
Why?
|
Antigens | 1 | 2003 | 1444 | 0.040 |
Why?
|
Diclofenac | 1 | 1998 | 69 | 0.040 |
Why?
|
Rhinitis | 1 | 2004 | 754 | 0.030 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 1998 | 251 | 0.030 |
Why?
|
Uveitis | 2 | 1977 | 398 | 0.030 |
Why?
|
Sex Factors | 2 | 2009 | 10641 | 0.030 |
Why?
|
Preservatives, Pharmaceutical | 2 | 1994 | 34 | 0.030 |
Why?
|
Prevalence | 3 | 2003 | 15875 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2002 | 6242 | 0.030 |
Why?
|
Mucins | 1 | 1998 | 571 | 0.030 |
Why?
|
Hyaluronic Acid | 1 | 1998 | 488 | 0.030 |
Why?
|
Oxamic Acid | 1 | 1994 | 2 | 0.030 |
Why?
|
Vitreous Body | 1 | 1976 | 400 | 0.030 |
Why?
|
Incidence | 3 | 2003 | 21545 | 0.030 |
Why?
|
Headache | 1 | 2002 | 1263 | 0.030 |
Why?
|
Cytokines | 1 | 2009 | 7453 | 0.030 |
Why?
|
Glycoproteins | 1 | 1981 | 2202 | 0.030 |
Why?
|
Phenylephrine | 2 | 1988 | 293 | 0.030 |
Why?
|
United States | 5 | 2005 | 73180 | 0.030 |
Why?
|
Drug Combinations | 3 | 1998 | 2088 | 0.030 |
Why?
|
Drug Costs | 1 | 2001 | 1198 | 0.030 |
Why?
|
Age Factors | 2 | 2009 | 18454 | 0.030 |
Why?
|
Animals | 16 | 2005 | 169408 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2004 | 10397 | 0.030 |
Why?
|
Infant | 5 | 2009 | 36541 | 0.030 |
Why?
|
Linolenic Acids | 1 | 1992 | 7 | 0.030 |
Why?
|
Area Under Curve | 1 | 2016 | 1645 | 0.030 |
Why?
|
Epithelium | 5 | 1998 | 1607 | 0.020 |
Why?
|
Povidone-Iodine | 1 | 1992 | 56 | 0.020 |
Why?
|
Reference Standards | 2 | 2008 | 1014 | 0.020 |
Why?
|
Random Allocation | 3 | 1994 | 2396 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1994 | 584 | 0.020 |
Why?
|
Risk Assessment | 2 | 2003 | 24330 | 0.020 |
Why?
|
Aspirin | 1 | 1983 | 3135 | 0.020 |
Why?
|
Pediatrics | 1 | 2006 | 3628 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2003 | 3489 | 0.020 |
Why?
|
Guinea Pigs | 2 | 2004 | 1309 | 0.020 |
Why?
|
Virus Diseases | 1 | 1977 | 724 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 1993 | 660 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2003 | 4077 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2003 | 11119 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20776 | 0.020 |
Why?
|
Wound Healing | 2 | 1992 | 2815 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3629 | 0.020 |
Why?
|
Forms and Records Control | 1 | 1989 | 158 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2024 | 81892 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2001 | 5544 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1995 | 3814 | 0.020 |
Why?
|
Aqueous Humor | 1 | 1989 | 152 | 0.020 |
Why?
|
Therapeutic Equivalency | 1 | 2008 | 134 | 0.020 |
Why?
|
Postoperative Complications | 2 | 1989 | 15889 | 0.020 |
Why?
|
Timolol | 1 | 1988 | 51 | 0.020 |
Why?
|
Nasal Obstruction | 1 | 2010 | 163 | 0.020 |
Why?
|
Glucocorticoids | 2 | 1993 | 2167 | 0.020 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2009 | 187 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1994 | 1445 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 1992 | 565 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 1990 | 610 | 0.020 |
Why?
|
Biopsy | 3 | 2005 | 6805 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1989 | 2087 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 1990 | 542 | 0.020 |
Why?
|
Pharyngitis | 1 | 1989 | 222 | 0.020 |
Why?
|
Premedication | 1 | 1988 | 246 | 0.020 |
Why?
|
Adhesives | 1 | 2007 | 67 | 0.020 |
Why?
|
Prednisolone | 1 | 1988 | 327 | 0.020 |
Why?
|
Pupil | 1 | 1988 | 146 | 0.020 |
Why?
|
Aminoglycosides | 1 | 1987 | 161 | 0.020 |
Why?
|
Anesthesia, Local | 1 | 1989 | 279 | 0.020 |
Why?
|
Lipoxygenase Inhibitors | 1 | 1987 | 93 | 0.020 |
Why?
|
Cytoplasmic Granules | 1 | 1989 | 574 | 0.020 |
Why?
|
Equipment Contamination | 1 | 1987 | 183 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1981 | 2488 | 0.020 |
Why?
|
Immunization | 1 | 2010 | 1219 | 0.020 |
Why?
|
Lidocaine | 1 | 1989 | 546 | 0.020 |
Why?
|
Research Design | 1 | 2002 | 6213 | 0.020 |
Why?
|
Chemotaxis | 1 | 1989 | 600 | 0.020 |
Why?
|
Bupivacaine | 1 | 1989 | 413 | 0.020 |
Why?
|
Aza Compounds | 1 | 2005 | 34 | 0.020 |
Why?
|
Ofloxacin | 1 | 2005 | 66 | 0.020 |
Why?
|
Arachidonic Acid | 1 | 1987 | 429 | 0.020 |
Why?
|
Forecasting | 1 | 1994 | 2946 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1989 | 619 | 0.010 |
Why?
|
Epinephrine | 1 | 1988 | 794 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 1973 | 1546 | 0.010 |
Why?
|
Prostaglandins D | 1 | 1983 | 27 | 0.010 |
Why?
|
Ciprofloxacin | 1 | 2005 | 313 | 0.010 |
Why?
|
Urticaria Pigmentosa | 1 | 1983 | 16 | 0.010 |
Why?
|
Corneal Ulcer | 2 | 1989 | 125 | 0.010 |
Why?
|
Benzalkonium Compounds | 2 | 1994 | 22 | 0.010 |
Why?
|
Aphakia | 1 | 1983 | 26 | 0.010 |
Why?
|
Eosinophil Granule Proteins | 1 | 1983 | 29 | 0.010 |
Why?
|
Neovascularization, Pathologic | 2 | 1990 | 2634 | 0.010 |
Why?
|
Pseudomonas Infections | 1 | 1987 | 623 | 0.010 |
Why?
|
Prostaglandin D2 | 1 | 1983 | 108 | 0.010 |
Why?
|
Dietary Fats | 1 | 1990 | 2003 | 0.010 |
Why?
|
Bradykinin | 1 | 1983 | 205 | 0.010 |
Why?
|
Bacteria | 1 | 1973 | 2219 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 1988 | 749 | 0.010 |
Why?
|
Lysophospholipase | 1 | 1981 | 66 | 0.010 |
Why?
|
Visual Fields | 1 | 2009 | 1067 | 0.010 |
Why?
|
Sulfones | 1 | 2004 | 448 | 0.010 |
Why?
|
Prostaglandins | 1 | 1983 | 398 | 0.010 |
Why?
|
Chronic Disease | 1 | 2017 | 9384 | 0.010 |
Why?
|
Dimaprit | 1 | 1981 | 5 | 0.010 |
Why?
|
Mucous Membrane | 1 | 1984 | 659 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2005 | 2299 | 0.010 |
Why?
|
Cimetidine | 1 | 1981 | 76 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2016 | 14751 | 0.010 |
Why?
|
Thiourea | 1 | 1981 | 68 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 2 | 1994 | 945 | 0.010 |
Why?
|
Tetracyclines | 1 | 1980 | 64 | 0.010 |
Why?
|
Methods | 1 | 1981 | 1066 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1989 | 1397 | 0.010 |
Why?
|
Arthralgia | 1 | 2004 | 459 | 0.010 |
Why?
|
Antipyrine | 1 | 1980 | 40 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2005 | 1737 | 0.010 |
Why?
|
Capillary Permeability | 1 | 2004 | 773 | 0.010 |
Why?
|
Polymers | 1 | 2007 | 1632 | 0.010 |
Why?
|
Nasal Mucosa | 1 | 2003 | 416 | 0.010 |
Why?
|
Transplantation, Homologous | 2 | 1980 | 4835 | 0.010 |
Why?
|
Cohort Studies | 2 | 1993 | 41800 | 0.010 |
Why?
|
Tetrahydronaphthalenes | 1 | 1980 | 86 | 0.010 |
Why?
|
Quinolines | 1 | 2005 | 772 | 0.010 |
Why?
|
Biochemistry | 1 | 1980 | 116 | 0.010 |
Why?
|
Complement System Proteins | 1 | 1983 | 738 | 0.010 |
Why?
|
Nonprescription Drugs | 1 | 1980 | 119 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 1998 | 316 | 0.010 |
Why?
|
Ketorolac Tromethamine | 1 | 1998 | 21 | 0.010 |
Why?
|
Chondroitin Sulfates | 1 | 1998 | 174 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1998 | 424 | 0.010 |
Why?
|
Serotonin | 1 | 1983 | 1045 | 0.010 |
Why?
|
Anterior Chamber | 1 | 1998 | 194 | 0.010 |
Why?
|
Uveitis, Anterior | 1 | 1978 | 102 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1993 | 13020 | 0.010 |
Why?
|
Blood Proteins | 1 | 1983 | 1191 | 0.010 |
Why?
|
Subacute Sclerosing Panencephalitis | 1 | 1977 | 26 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1980 | 2560 | 0.010 |
Why?
|
Uveal Diseases | 1 | 1977 | 45 | 0.010 |
Why?
|
Reflex, Abnormal | 1 | 1977 | 83 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 1989 | 3858 | 0.010 |
Why?
|
Dermatitis, Atopic | 1 | 1984 | 737 | 0.010 |
Why?
|
Recurrence | 2 | 1980 | 8512 | 0.010 |
Why?
|
Behcet Syndrome | 1 | 1977 | 86 | 0.010 |
Why?
|
Neutrophils | 1 | 1989 | 3785 | 0.010 |
Why?
|
Glycosylation | 1 | 1998 | 1101 | 0.010 |
Why?
|
Coloring Agents | 1 | 1998 | 564 | 0.010 |
Why?
|
Lacrimal Apparatus | 1 | 1976 | 223 | 0.010 |
Why?
|
Herpes Zoster | 1 | 1977 | 252 | 0.010 |
Why?
|
Buffers | 1 | 1994 | 143 | 0.010 |
Why?
|
Proteus mirabilis | 1 | 1973 | 24 | 0.010 |
Why?
|
Endothelium | 1 | 1976 | 768 | 0.010 |
Why?
|
Corynebacterium | 1 | 1973 | 49 | 0.010 |
Why?
|
Staphylococcus | 1 | 1973 | 146 | 0.010 |
Why?
|
Plasma Cells | 1 | 1976 | 599 | 0.010 |
Why?
|
Streptococcus | 1 | 1973 | 198 | 0.010 |
Why?
|
Simplexvirus | 1 | 1976 | 805 | 0.010 |
Why?
|
Rats | 1 | 1989 | 23847 | 0.010 |
Why?
|
gamma-Linolenic Acid | 1 | 1992 | 16 | 0.010 |
Why?
|
Drug Hypersensitivity | 1 | 1981 | 923 | 0.010 |
Why?
|
Sodium Hydroxide | 1 | 1990 | 37 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1984 | 3116 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 1977 | 839 | 0.010 |
Why?
|
Phosphates | 1 | 1994 | 765 | 0.010 |
Why?
|
Movement | 1 | 1977 | 1490 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1994 | 1585 | 0.010 |
Why?
|
Paper | 1 | 1989 | 83 | 0.010 |
Why?
|
Corneal Edema | 1 | 1989 | 45 | 0.000 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1990 | 394 | 0.000 |
Why?
|
Filtration | 1 | 1989 | 228 | 0.000 |
Why?
|
Eicosanoids | 1 | 1990 | 284 | 0.000 |
Why?
|
Mathematics | 1 | 1989 | 704 | 0.000 |
Why?
|
Inflammation | 2 | 1990 | 10869 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1984 | 10276 | 0.000 |
Why?
|
Intraoperative Period | 1 | 1988 | 513 | 0.000 |
Why?
|
Pharynx | 1 | 1989 | 436 | 0.000 |
Why?
|
Photography | 1 | 1989 | 537 | 0.000 |
Why?
|
Antiviral Agents | 1 | 1978 | 3069 | 0.000 |
Why?
|
New England | 1 | 1989 | 1058 | 0.000 |
Why?
|
Acetylcholine | 1 | 1988 | 629 | 0.000 |
Why?
|
Influenza, Human | 1 | 1977 | 1541 | 0.000 |
Why?
|
Methylmethacrylates | 1 | 1983 | 67 | 0.000 |
Why?
|
Povidone | 1 | 1983 | 31 | 0.000 |
Why?
|
Cell Cycle | 1 | 1992 | 2937 | 0.000 |
Why?
|
Refraction, Ocular | 1 | 1983 | 188 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 1998 | 9264 | 0.000 |
Why?
|
Postoperative Care | 1 | 1988 | 1481 | 0.000 |
Why?
|
Cell Movement | 1 | 1989 | 5216 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1989 | 3701 | 0.000 |
Why?
|
Prostheses and Implants | 1 | 1983 | 1279 | 0.000 |
Why?
|
Models, Statistical | 1 | 1989 | 5107 | 0.000 |
Why?
|
Cell Count | 1 | 1976 | 1833 | 0.000 |
Why?
|
Organ Size | 1 | 1976 | 2268 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1989 | 18366 | 0.000 |
Why?
|
Prognosis | 1 | 1989 | 30044 | 0.000 |
Why?
|